Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 21, 2023
Reduction in <sup>99m</sup>Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathyRené Rettl, Raffaella Calabretta, Franz Duca, et al.
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
JACC. Heart Failure|October 13, 2023
Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF TrialMaria Pabon, Jon Cunningham, Brian Claggett, et al.
International Journal of Cardiology|December 12, 2018
Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018Stephan Rosenkranz, Irene M Lang, Rüdiger Blindt, et al.
Scientific Reports|June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic ratsPhilipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
Biology|August 26, 2022
Neutrophile-Lymphocyte Ratio and Outcome in Takotsubo SyndromeDavid Zweiker, Edita Pogran, Laura Gargiulo, et al.
International Journal of Cardiology|January 7, 2012
Pulmonary hypertension due to left heart disease: updated Recommendations of the Cologne Consensus Conference 2011Stephan Rosenkranz, Diana Bonderman, Michael Buerke, et al.
European Heart Journal. Cardiovascular Imaging|August 7, 2023
Myocardial structural and functional changes in cardiac amyloidosis: insights from a prospective observational patient registryFranz Duca, René Rettl, Christina Kronberger, et al.
European Journal of Heart Failure|February 21, 2020
Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcomeChristian Nitsche, Stefan Aschauer, Andreas A Kammerlander, et al.
European Heart Journal|June 8, 2022
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trialMarco Metra, Matteo Pagnesi, Brian L Claggett, et al.
Pageof 13